Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

183.74 -6.67 (-3.50%)
Streaming Delayed Price Updated: 3:15 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
7 Stocks to Buy as America Lifts Its Travel Ban
With the Biden administration making the move to open U.S. land borders with Canada and Mexico, these stocks to buy can get a boost. 
Via InvestorPlace
Quest Diagnostics Receives Coveted Koop Award
SOURCE: Quest Diagnostics 
Via 3BL Media
Why This Diagnostics Stock Is a Buy
Quest Diagnostics beat analysts' estimates in the third quarter and raised its guidance for this year again. 
Via The Motley Fool
ICYMI: Collaborating to Address Health Inequities in Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers
Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition... 
Via Benzinga
Quest Named to Forbes List of World's Best Employers 2021
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics Gives Colleagues a "High 5"
SOURCE: Quest Diagnostics 
Via 3BL Media
Give it a Shot: The Latest on the Flu & COVID Vaccine
SOURCE: Quest Diagnostics 
Via 3BL Media
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – New at-home Covid tests are on the way, according to the Biden administration, which announced... 
Via FinancialNewsMedia
Bluford Healthcare Leadership Institute Empowering Greater Equity Among Future Healthcare Leaders
SOURCE: Quest Diagnostics 
Via 3BL Media
Webinar: Collaborating to Address Health Inequities in Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Regulatory Compliance
What 5 Analyst Ratings Have To Say About Quest Diagnostics
Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the follow... 
Via Benzinga
Our Commitment to a Diverse Workforce and Equitable Compensation
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Supply Chain
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
DGX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Quest Diagnostics: Q3 Earnings Insights
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Supporting Employees' Emotional Health During the Pandemic
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales... 
Via Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine... 
Via Benzinga
Earnings Scheduled For October 21, 2021
Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •... 
Via Benzinga
Earnings Outlook For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Price Over Earnings Overview: Quest Diagnostics
Right now, Quest Diagnostics Inc. (NYSE:DGX) share price is at $145.77, after a 1.43% gain. Moreover, over the past month, the stock fell by 5.60%, but in the past... 
Via Benzinga
Communities of Color Hit Hardest by COVID-19 and Lack Trust in Healthcare
SOURCE: Quest Diagnostics 
Via 3BL Media
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... 
Via Benzinga
DA Authorizes Quest Diagnostics' COVID-19 Collection Materials for Emergency Use
SOURCE: Quest Diagnostics 
Via 3BL Media
Reducing Health Inequities While Expanding the Pipeline to Create a More Diverse Health Care Workforce
SOURCE: Quest Diagnostics 
Via 3BL Media
Addressing the Healthcare Needs of Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Over Half of U.S. Children Have Detectable Levels of Lead in Their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Energy
The Delta Variant Has Made Quest Diagnostics Indispensable
On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.